I don’t think so, unless they are trying to look at some other factor specifically for males.
A lot of Pharmas will not even accept condoms as a contraception method alone anymore & CROs need to just go with protocol. (7) It’s a stock standard inclusion/exclusion criteria for clinical trials & I don’t think that is why a trial of n=84 in Ph 1 were all male, there maybe was something else they were looking at (undisclosed)? Interesting all the same @silsol. Maybe some Viagra like effect? Lol
Ann: Appendix 4C and Quarterly Report - March 2020, page-25
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $52.32M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $149.9K | 473.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7853 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 27908 | 1 |
View Market Depth
| Last trade - 13.43pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |